September 30, 2024 | by Fraunhofer CIMD, hosted by Fraunhofer ITEM
© nobeastsofierce, stock.adobe.com
Let's focus on RNA-based therapeutics together - on September 30! Hear expert talks, visit the poster exhibition, discuss current challenges and questions and exchange with international colleagues
We look forward to welcoming you at Fraunhofer ITEM in September 2024!
Click here to read the program.
Online registration at the website of Fraunhofer ISC.
Early-bird (until July 14, 2024):
- Academic research affiliates: 120 EUR
- Students: 60 EUR
- Industry: 180 EUR
Late
- Academic research affiliates: 160 EUR
- Students: 100 EUR
- Industry: 220 EUR
Registration deadline: extended to September 20, 2024
CRC Hannover - Clinical Research Center Hannover
Feodor-Lynen-Str. 15
30625 Hannover
September 30, 2024, 12:00-20:00 Uhr
English
as of August 28, 2024; subject to change without notice
11:45 |
Welcome Norbert Krug and Christian Bär, Fraunhofer ITEM, Hannover (Germany) |
Session 1: Target discovery and lead optimization Chair: Lena Wiese, Fraunhofer ITEM / GU Frankfurt, Hannover/Frankfurt (Germany) |
|
12:00 |
Investigating early mechanisms and potential targets in virus-induced COPD exacerbations through in silico modeling Mats Jirstrand and Mikael Wallman, Fraunhofer Chalmers, Göteborg (Sweden) |
12:20 |
Integrative bioinformatics analysis of RNA targets in immune-mediated diseases Meik Kunz, Fraunhofer ITEM / FAU Erlangen, Hannover/Erlangen (Germany) |
12:40 |
Parallel screening of barcoded LNP formulations in vivo for organ-specific RNA delivery Malte Juchem, Hannover Medical School / Fraunhofer ITEM, Hannover (Germany) |
Session 2: Advanced human preclinical models Chair: Katherina Sewald, Fraunhofer ITEM (Germany) |
|
13:00 |
Targeting immune cells to facilitate the development of novel therapies Nico Lachmann, Fraunhofer ITEM / Hannover Medical School, Hannover (Germany) |
13:20 |
The development of in vitro skin models: From simple epidermis to complex hiPSC-derived organoids models Dieter Groneberg, Fraunhofer ISC - TLZ-RT, Würzburg (Germany) |
13:40 |
Multi-cellular human cardiac organoids, a versatile platform for modelling cardiovascular disease Elisa Mohr, Hannover Medical School, Hannover (Germany) |
14:00 |
Poster viewing (I) |
Special Session (I): Innovations towards clinical application Chair: Christian Bär, Fraunhofer ITEM / Hannover Medical School, Hannover (Germany) |
|
14:30 |
RNAuto – automated production technologies of mRNA-based vaccines and cell therapies Sandy Tretbar, Fraunhofer IZI, Leipzig (Germany) |
14:50 |
Translational development of inhaled antiviral RNAi fighting parainfluenza infection Armin Braun, Fraunhofer ITEM, Hannover (Germany) |
15:10 |
Advancing respiratory delivery utilizing new inhaler technologies Gerhard Pohlmann, Fraunhofer ITEM, Hannover (Germany) |
Session 3: Targeted delivery strategies Chair: Jan Fiedler, Fraunhofer ITEM, Hannover (Germany) |
|
15:30 |
Glycobiotechnology as a tool for drug delivery Sophia Rosencrantz, Fraunhofer IAP, Potsdam (Germany) |
15:50 |
Particle-based solutions for RNA encapsulation Sofia Dembski, Fraunhofer ISC - TLZ-RT, Würzburg (Germany) |
16:10 |
Polymeric PEI/PPI-based nanoparticles as non-viral platform technology for RNA delivery in vivo and ex vivo Achim Aigner, Leipzig University, Leipzig (Germany) |
16:30 |
Optimizing the properties of lipid nanoparticles through advanced manufacturing technologies Christoph Hein, Fraunhofer IPK, Berlin (Germany) |
16:50 |
Poster viewing (II) |
Session 4: RNA clinical development Chair: Christian Bär, Fraunhofer ITEM / Hannover Medical School, Hannover (Germany) |
|
17:20 |
Clinical development & regulatory affairs for RNA therapies Philipp Badorrek, Fraunhofer ITEM, Hannover (Germany) |
17:40 |
Survey lecture: miRNA therapies on their way towards clinical application Christian Bär, Fraunhofer ITEM / Hannover Medical School, Hannover (Germany) |
Special Session (II): Industry perspective Chair: Ruben R. Rosencrantz, Fraunhofer IAP, Potsdam (Germany) |
|
18:00 |
mRNA-based therapies for personalized cancer vaccines - Specific requirements and challenges Tilmann Roos – Senior Director Technical Solutions, CureVac RNA Printer GmbH (Tübingen, Germany) |
18:20 |
The importance of excipients for RNA therapeutics - Current trends and future perspectives in research and industry Thomas Endres - Head of New Products and Materials | Health Care, Evonik Operations GmbH (Darmstadt, Germany) |
18:40 |
Trans-amplifying RNA Tim Beißert - Head Vectors Unit, TRON gGmbH (Mainz, Germany) |
Evening session |
|
19:00 |
Poster viewing with fingerfood reception |
19:55 |
Poster award ceremony |
20:00 |
End |
For all other questions regarding the symposium, please contact:
Fraunhofer Institute for Toxicology and Experimental Medicine
